2 Results for "

linical development

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "linical development" in MCE Product Catalog:

Cat. No.: HY-145939
CAS No.: 2468783-75-5
Purity:  98.27%
Synonyms: BRD5846
Target:  

Casein Kinase

Research Areas:  

Cancer

BAY-888 is a selective CK1α/CSNK1A1 (casein kinase 1α) ATP-competitive inhibitor (IC50: 4 nM@10 μM ATP; 63 nM@1 mM ATP). BAY-888 blocks the negative regulation of p53 and other signaling pathways by CK1α, induces apoptosis and inhibits proliferation of tumor cells. BAY-888 has shown inhibitory efficacy against cancers such as acute myeloid leukemia (AML) in PRISM barcoded cell line screening and can mimic the effects of shRNA-mediated CK1α knockdown. BAY-888 is primarily used for the development of anticancer drugs for p53 wild-type tumors and for the study of the mechanisms of CK1α-related signaling pathways .
loading...
    loading...
Cat. No.: HY-W665882
CAS No.: 34580-20-6
Norketotifen is the active metabolite of Ketotifen (HY-B0157). Norketotifen exhibits skin anti-inflammatory activity, anti-malarial activity, and antipruritic activity against non-histamine-mediated dog itching in mice. Norketotifen effectively inhibits TNF-α release without causing any sedative side effects. Norketotifen can be used for research on non-sedating anti-inflammatory agents .
loading...
    loading...